Table of Contents
<< Previous Issue | Sep 2015 (Vol: 2015, Issue: 9) | Next Issue >> |
- Section: Licensing
-
Aveo Looks to Brighter Future with Novartis Licensing Deal
-
Valeant Licenses Rights to AstraZeneca’s Troubled Psoriasis Drug Brodalumab
- Section: Mergers & Acquisitions
-
Mallinckrodt Continues M&A Spree with US$1.325 B Therakos Acquisition
-
Amicus Expands Rare Disease Pipeline with Scioderm Acquisition